New Pre-Surgery combo aims to shrink lung tumors
NCT ID NCT07493980
Summary
This study is testing a three-drug combination (JSKN016, toripalimab, and carboplatin) given to patients before they have surgery for stage II or III non-small cell lung cancer. The goal is to see if this treatment can shrink or eliminate the tumor in the lung and nearby lymph nodes to make surgery more successful. Researchers will measure how well the tumors respond, how many patients can complete surgery, and monitor side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC STAGE II are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, 200433, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.